Stockscreener 앱 받기
0.7134
20.18%
0.1198
시간 외 거래:
.69
-0.0234
-3.28%
전일 마감가:
$0.5936
열려 있는:
$0.6078
하루 거래량:
5.97M
Relative Volume:
0.47
시가총액:
$25.91M
수익:
-
순이익/손실:
$-23.36M
주가수익비율:
-0.9682
EPS:
-0.7368
순현금흐름:
-
1주 성능:
+23.21%
1개월 성능:
+154.33%
6개월 성능:
-14.52%
1년 성능:
-59.47%
1일 변동 폭
$0.6001
$0.7584
1주일 범위
$0.47
$0.7584
52주 변동 폭
$0.2027
$3.89
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
명칭
Calidi Biotherapeutics Inc
전화
(858) 794-9600
주소
4475 Executive Drive, Suite 200, San Diego
CLDI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
0.7134 | 19.99M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-22 | 개시 | H.C. Wainwright | Buy |
| 2023-10-09 | 개시 | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
Is Calidi Biotherapeutics Inc. a good long term investmentSuperior returns - Autocar Professional
Calidi Biotherapeutics Inc. Stock Analysis and ForecastExplosive portfolio gains - Autocar Professional
What drives Calidi Biotherapeutics Inc. stock priceExceptional profit margins - Autocar Professional
What analysts say about Calidi Biotherapeutics Inc. stockDouble or triple returns - Jammu Links News
What risks could impact Calidi Biotherapeutics Inc. stock performanceFree Stock Trading Community - Newser
What makes Calidi Biotherapeutics Inc. stock price move sharplyFree Professional Portfolio Management - Newser
Why Calidi Biotherapeutics Inc. stock attracts strong analyst attentionFree Best Performing Stock Suggestions - Newser
How Calidi Biotherapeutics Inc. stock performs during market volatilityMarket Beating Strategy - Newser
Calidi Biotherapeutics Inc Inc. (CLDI) Price Performance: A Comparative Analysis with Competitors - investchronicle.com
Calidi Biotherapeutics Approves Key Proposals at Annual Meeting - TipRanks
Calidi Biotherapeutics Plummets 27%—Can Biotech Breakthroughs Stem the Slide? - AInvest
Calidi Biotherapeutics Plunges 4.81% Amid Bridge Financing - AInvest
Top Penny Stocks To Add to Your Watchlist – July 9th - Defense World
MarketsMedicine Hat News - FinancialContent
Calidi Biotherapeutics Announces Inducement Offer Agreement - TipRanks
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Quantisnow
Calidi Biotherapeutics: Redefining Cancer Treatment with Breakthrough Virotherapy - AInvest
Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment - The Manila Times
Breakthrough Cancer Treatment: Calidi's New Genetic Platform Targets Both Primary and Metastatic Tumors - Stock Titan
Calidi Biotherapeutics Cashes In On Warrant Agreement - Finimize
Calidi Biotherapeutics secures $4.6 million through warrant exercise - Investing.com Australia
Calidi Biotherapeutics secures $4.6 million through warrant exercise By Investing.com - Investing.com Nigeria
Calidi Biotherapeutics to Raise $4.6 Million Through Warrant Exercise Agreement - MarketScreener
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers - The Malaysian Reserve
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds - The Manila Times
Clinical-Stage Biotech Calidi Raises $4.6M in Fresh Capital: Accelerates Targeted Therapy Programs - Stock Titan
Crude Oil Moves Higher; RxSight Shares Plunge - Benzinga
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May - Benzinga
Calidi Biotherapeutics Stock Soars 174.93% on Precision Medicine Hype - AInvest
Calidi Biotherapeutics Soars 119.7% on Cancer Trial News - AInvest
Calidi Biotherapeutics Stock Jumps 39% After Hours — What's Going On - Benzinga
ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
Revolutionary Cancer Treatment: How Engineered Viruses Could Transform Genetic Medicine Delivery - Stock Titan
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs – Company AnnouncementFT.com - Financial Times
Calidi Biotherapeutics (CLDI): A Breakthrough in Systemic Virotherapy and the $564B Oncology Opportunity - AInvest
Calidi Biotherapeutics Inc (CLDI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):